W&I joins national endometriosis study

PROVIDENCE – Researchers in the Center for Reproduction and Infertility at Women & Infants Hospital of Rhode Island have launched an arm of a national endometriosis study, known as SOLSTICE, evaluating the safety and effectiveness of an investigational drug to help women with moderate to severe endometriosis pain symptoms.

“The goal of SOLSTICE is to evaluate an orally active gonadotropin-releasing hormone (GnRH) antagonist in the management of endometriosis-related pain,” said Dr. Kelly Pagidas, interim director of the Center for Reproduction and Infertility and principal investigator of the Women & Infants arm of the study.

Endometriosis is the growth of tissue lining the uterus outside of the uterus on other organs or structures in the body, most commonly on the ovaries, Fallopian tubes, the outer surface of the uterus or the lining of the pelvic cavity. At least 5.5 million women in North America have endometriosis, which can lead to very painful cramps or periods, heavy periods, chronic pelvic pain, intestinal pain, and infertility.

To volunteer for the SOLSTICE study, women can go to SolsticeResearch.com, text ENDO1 to 87888, or call Courtney Bodge, at the Center for Reproduction and Infertility at (401) 453-7500, ext. 48422.

- Advertisement -

No posts to display